We aimed to estimate the effect of the apolipoprotein E (APOE) ε4 allele, the best known genetic risk factor for AD aside from variations in APP, PSEN1, and PSEN2, on performance for outcomes most sensitive to cognitive changes. The gene discussed is APP; the disease is Alzheimer disease.